Literature DB >> 9063344

Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study.

K M Brett1, J H Madans.   

Abstract

The objective of this study was to describe trends in the use of hormone replacement therapy (HRT) in the United States by demographic, life-style, and heart disease risk factors. Data were obtained from the Epidemiologic Followup Study to the First National Health and Nutrition Examination Survey, a nationally representative cohort followed from the mid-1970s until 1992. A total of 5,602 women who had become menopausal by their last follow-up interview were included. An estimated 45% of the cohort of menopausal US women 25-74 years of age in the early 1970s used HRT for at least one month and 20% continued use for 5 or more years. Between 1987 and 1992, as the younger members of the cohort became menopausal, the proportion of this cohort who had ever used HRT and used it for 5 or more years increased by 32% and 54%, respectively. A higher probability of HRT use was found among women who were white, who were more highly educated, and who lived in the West, or who had experienced a surgical menopause. Women who were overweight or who abstained from alcohol were less likely to use HRT. These data support the hypothesis that HRT use is associated with sociodemographic factors, and that women tend to discontinue use within several years.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9063344     DOI: 10.1093/oxfordjournals.aje.a009142

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  42 in total

Review 1.  Effect of SERMs on breast tissue.

Authors:  S R Goldstein
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

Review 2.  Postmenopausal hormone therapy, SERMs, and coronary heart disease in women.

Authors:  N K Wenger; D Grady
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

3.  Low use of long-term hormone replacement therapy in Denmark.

Authors:  C Olesen; F H Steffensen; H T Sørensen; G L Nielsen; J Olsen; U Bergman
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

4.  Use of postmenopausal estrogen replacement therapy from 1981 to 1997.

Authors:  Ilona Csizmadi; Andrea Benedetti; Jean-François Boivin; James A Hanley; Jean-Paul Collet
Journal:  CMAJ       Date:  2002-01-22       Impact factor: 8.262

5.  Self-reported changes in providers' hormone therapy prescribing and counseling practices after the Women's Health Initiative.

Authors:  Susan L Lakey; Susan D Reed; Andrea Z LaCroix; Lou Grothaus; Katherine M Newton
Journal:  J Womens Health (Larchmt)       Date:  2010-11-09       Impact factor: 2.681

Review 6.  Healthy user and related biases in observational studies of preventive interventions: a primer for physicians.

Authors:  William H Shrank; Amanda R Patrick; M Alan Brookhart
Journal:  J Gen Intern Med       Date:  2011-01-04       Impact factor: 5.128

Review 7.  Hormone replacement therapy and breast cancer: estimate of risk.

Authors:  Nathan J Coombs; Richard Taylor; Nicholas Wilcken; John Boyages
Journal:  BMJ       Date:  2005-08-06

8.  Developing profiles of postmenopausal women being prescribed estrogen therapy to prevent osteoporosis.

Authors:  Mayur M Amonkar; Reema Mody
Journal:  J Community Health       Date:  2002-10

9.  Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.

Authors:  L J Lambert; J A Y Straton; M W Knuiman; H C Bartholomew
Journal:  J Epidemiol Community Health       Date:  2003-04       Impact factor: 3.710

10.  Prediagnostic use of hormone therapy and mortality after breast cancer.

Authors:  Polly A Newcomb; Kathleen M Egan; Amy Trentham-Dietz; Linda Titus-Ernstoff; John A Baron; John M Hampton; Meir J Stampfer; Walter C Willett
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-04-01       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.